|
1.
|
Livraghi T, Mäkisalo H and Line PD:
Treatment options in hepatocellular carcinoma today. Scand J Surg.
100:22–29. 2011.PubMed/NCBI
|
|
2.
|
El-Serag HB: Epidemiology of viral
hepatitis and hepatocellular carcinoma. Gastroenterology.
142:1264–1273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
De Lope CR, Tremosini S, Forner A, Reig M
and Bruix J: Management of HCC. J Hepatol. 56(Suppl 1): S75–S87.
2012.
|
|
4.
|
Nishikawa H, Osaki Y, Iguchi E, Takeda H,
Matsuda F, Nakajima J, Sakamoto A, Hatamaru K, Saito S, Nasu A,
Kita R and Kimura T: Radiofrequency ablation for hepatocellular
carcinoma: the relationship between a new grading system for the
ablative margin and clinical outcomes. J Gastroenterol. Oct
12–2012.(Epub ahead of print).
|
|
5.
|
Nishikawa H, Arimoto A, Wakasa T, Kita R,
Kimura T and Osaki Y: Surgical resection for hepatocellular
carcinoma: clinical outcomes and safety in elderly patients. Eur J
Gastroenterol Hepatol. 25:912–919. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Umemura T, Ichijo T, Yoshizawa K, Tanaka E
and Kiyosawa K: Epidemiology of hepatocellular carcinoma in Japan.
J Gastroenterol. 44(Suppl 19): 102–107. 2009. View Article : Google Scholar
|
|
7.
|
Tokushige K, Hashimoto E, Horie Y, Taniai
M and Higuchi S: Hepatocellular carcinoma in Japanese patients with
nonalcoholic fatty liver disease, alcoholic liver disease, and
chronic liver disease of unknown etiology: report of the nationwide
survey. J Gastroenterol. 46:1230–1237. 2011. View Article : Google Scholar
|
|
8.
|
Kaibori M, Ishizaki M, Matsui K and Kwon
AH: Clinicopathologic characteristics of patients with non-B non-C
hepatitis virus hepatocellular carcinoma after hepatectomy. Am J
Surg. 204:300–307. 2012. View Article : Google Scholar
|
|
9.
|
Abe H, Yoshizawa K, Kitahara T, Aizawa R,
Matsuoka M and Aizawa Y: Etiology of non-B non-C hepatocellular
carcinoma in the eastern district of Tokyo. J Gastroenterol.
43:967–974. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Nagaoki Y, Hyogo H, Aikata H, Tanaka M,
Naeshiro N, Nakahara T, Honda Y, Miyaki D, Kawaoka T, Takaki S,
Hiramatsu A, Waki K, Imamura M, Kawakami Y, Takahashi S and Chayama
K: Recent trend of clinical features in patients with
hepatocellular carcinoma. Hepatol Res. 42:368–375. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Suzuki Y, Ohtake T, Nishiguchi S,
Hashimoto E, Aoyagi Y, Onji M and Kohgo Y: The Japan Non-B, Non-C
Liver Cirrhosis Study Group: Survey of non-B, non-C liver cirrhosis
in Japan. Hepatol Res. Dec 26–2012.(Epub ahead of print).
|
|
12.
|
Kim SK, Marusawa H, Eso Y, Nishikawa H,
Ueda Y, Kita R, Kimura T, Chiba T, Osaki Y and Kudo M: Clinical
characteristics of non-B non-C hepatocellular carcinoma: a
single-center retrospective study. Digestion. 84(Suppl 1): 43–49.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Bugianesi E, Leone N, Vanni E, Marchesini
G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L and
Salizzoni M: Expanding the natural history of nonalcoholic
steatohepatitis: from cryptogenic cirrhosis to hepatocellular
carcinoma. Gastroenterology. 123:134–140. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Marrero JA, Fontana RJ, Su GL, Conjeevaram
HS, Emick DM and Lok AS: NAFLD may be a common underlying liver
disease in patients with hepatocellular carcinoma in the United
States. Hepatology. 36:1349–1354. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Torres DM and Harrison SA: Nonalcoholic
steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile
soil. Semin Liver Dis. 32:30–38. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Calle EE, Rodriguez C, Walker-Thurmond K
and Thun MJ: Overweight, obesity, and mortality from cancer in a
prospectively studied cohort of US adults. N Engl J Med.
348:1625–1638. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Kaji K, Yoshiji H, Ikenaka Y, Noguchi R,
Aihara Y, Shirai Y, Douhara A and Fukui H: Possible involvement of
angiogenesis in chronic liver diseases: interaction among
renin-angiotensin-aldosterone system, insulin resistance and
oxidative stress. Curr Med Chem. 19:1889–1898. 2012. View Article : Google Scholar
|
|
18.
|
Yasui K, Hashimoto E, Tokushige K, Koike
K, Shima T, Kanbara Y, Saibara T, Uto H, Takami S, Kawanaka M and
Komorizono Y: Clinical and pathological progression of
non-alcoholic steatohepatitis to hepatocellular carcinoma. Hepatol
Res. 42:767–773. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Chung H, Ueda T and Kudo M: Changing
trends in hepatitis C infection over the past 50 years in Japan.
Intervirology. 53:39–43. 2010.PubMed/NCBI
|
|
20.
|
Schaefer EA and Chung RT: Anti-hepatitis C
virus drugs in development. Gastroenterology. 142:1340–1350. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Jacobson IM, Pawlotsky JM, Afdhal NH,
Dusheiko GM, Forns X, Jensen DM, Poordad F and Schulz J: A
practical guide for the use of boceprevir and telaprevir for the
treatment of hepatitis C. J Viral Hepat. 19(Suppl 2): 1–26. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Rosen HR: Clinical practice. Chronic
hepatitis C infection N Engl J Med. 364:2429–2438. 2011.PubMed/NCBI
|
|
23.
|
Ertle J, Dechêne A, Sowa JP, Penndorf V,
Herzer K, Kaiser G, Schlaak JF, Gerken G, Syn WK and Canbay A:
Non-alcoholic fatty liver disease progresses to hepatocellular
carcinoma in the absence of apparent cirrhosis. Int J Cancer.
128:2436–2443. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Donato F, Tagger A, Gelatti U, Parrinello
G, Boffetta P, Albertini A, Decarli A, Trevisi P, Ribero ML,
Martelli C, Porru S and Nardi G: Alcohol and hepatocellular
carcinoma: the effect of lifetime intake and hepatitis virus
infections in men and women. Am J Epidemiol. 155:323–331. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Corrao G, Bagnardi V, Zambon A and La
Vecchia C: A meta-analysis of alcohol consumption and the risk of
15 diseases. Prev Med. 38:613–619. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Sookoian S and Pirola CJ: The genetic
epidemiology of nonalcoholic fatty liver disease: toward a
personalized medicine. Clin Liver Dis. 16:467–485. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Shen L, Fan JG, Shao Y, Zeng MD, Wang JR,
Luo GH, Li JQ and Chen SY: Prevalence of nonalcoholic fatty liver
among administrative officers in Shanghai: an epidemiological
survey. World J Gastroenterol. 9:1106–1110. 2003.PubMed/NCBI
|
|
28.
|
Ong JP and Younossi ZM: Epidemiology and
natural history of NAFLD and NASH. Clin Liver Dis. 11:1–16. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Kojima S, Watanabe N, Numata M, Ogawa T
and Matsuzaki S: Increase in the prevalence of fatty liver in Japan
over the past 12 years: analysis of clinical background. J
Gastroenterol. 38:954–961. 2003.PubMed/NCBI
|
|
30.
|
Harrison SA, Torgerson S and Hayashi PH:
The natural history of nonalcoholic fatty liver disease: a clinical
histopathological study. Am J Gastroenterol. 98:2042–2047. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Powell EE, Cooksley WG, Hanson R, Searle
J, Halliday JW and Powell LW: The natural history of nonalcoholic
steatohepatitis: a follow-up study of forty-two patients for up to
21 years. Hepatology. 11:74–80. 1990.PubMed/NCBI
|
|
32.
|
Hashimoto E, Yatsuji S, Tobari M, Taniai
M, Torii N, Tokushige K and Shiratori K: Hepatocellular carcinoma
in patients with nonalcoholic steatohepatitis. J Gastroenterol.
44(Suppl 19): 89–95. 2009. View Article : Google Scholar
|
|
33.
|
Hashizume H, Sato K, Takagi H, Hirokawa T,
Kojima A, Sohara N, Kakizaki S, Mochida Y, Shimura T and Sunose Y:
Primary liver cancers with nonalcoholic steatohepatitis. Eur J
Gastroenterol Hepatol. 19:827–834. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Yoshioka Y, Hashimoto E, Yatsuji S, Kaneda
H, Taniai M, Tokushige K and Shiratori K: Nonalcoholic
steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out
NASH. J Gastroenterol. 39:1215–1218. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Ayata G, Gordon FD, Lewis WD, Pomfret E,
Pomposelli JJ, Jenkins RL and Khettry U: Cryptogenic cirrhosis:
clinicopathologic findings at and after liver transplantation. Hum
Pathol. 33:1098–1104. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Starley BQ, Calcagno CJ and Harrison SA:
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a
weighty connection. Hepatology. 51:1820–1832. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Ascha MS, Hanouneh IA, Lopez R, Tamimi TA,
Feldstein AF and Zein NN: The incidence and risk factors of
hepatocellular carcinoma in patients with nonalcoholic
steatohepatitis. Hepatology. 51:1972–1978. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Yatsuji S, Hashimoto E, Tobari M, Taniai
M, Tokushige K and Shiratori K: Clinical features and outcomes of
cirrhosis due to non-alcoholic steatohepatitis compared with
cirrhosis caused by chronic hepatitis C. J Gastroenterol Hepatol.
24:248–254. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Welzel TM, Graubard BI, Zeuzem S, El-Serag
HB, Davila JA and McGlynn KA: Metabolic syndrome increases the risk
of primary liver cancer in the United States: a study in the
SEER-Medicare database. Hepatology. 54:463–471. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
El-Serag HB, Tran T and Everhart JE:
Diabetes increases the risk of chronic liver disease and
hepatocellular carcinoma. Gastroenterology. 126:460–468. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Wang C, Wang X, Gong G, Ben Q, Qiu W, Chen
Y, Li G and Wang L: Increased risk of hepatocellular carcinoma in
patients with diabetes mellitus: a systematic review and
meta-analysis of cohort studies. Int J Cancer. 130:1639–1648. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Neuschwander-Tetri BA and Caldwell SH:
Nonalcoholic steatohepatitis: summary of an AASLD Single Topic
Conference. Hepatology. 37:1202–1219. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Garcia-Compean D, Jaquez-Quintana JO,
Gonzalez-Gonzalez JA and Maldonado-Garza H: Liver cirrhosis and
diabetes: risk factors, pathophysiology, clinical implications and
management. World J Gastroenterol. 15:280–288. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Allison ME, Wreghitt T, Palmer CR and
Alexander GJ: Evidence for a link between hepatitis C virus
infection and diabetes mellitus in a cirrhotic population. J
Hepatol. 21:1135–1139. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
El-Serag HB, Johnson ML, Hachem C and
Morgana RO: Statins are associated with a reduced risk of
hepatocellular carcinoma in a large cohort of patients with
diabetes. Gastroenterology. 136:1601–1608. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Ohata K, Hamasaki K, Toriyama K, Matsumoto
K, Saeki A, Yanagi K, Abiru S, Nakagawa Y, Shigeno M, Miyazoe S,
Ichikawa T, Ishikawa H, Nakao K and Eguchi K: Hepatic steatosis is
a risk factor for hepatocellular carcinoma in patients with chronic
hepatitis C virus infection. Cancer. 97:3036–3043. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Shimizu M, Tanaka T and Moriwaki H:
Obesity and hepatocellular carcinoma: targeting obesity-related
inflammation for chemoprevention of liver carcinogenesis. Semin
Immunopathol. 35:191–202. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Bianchini F, Kaaks R and Vainio H:
Overweight, obesity, and cancer risk. Lancet Oncol. 3:565–574.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Larsson SC and Wolk A: Overweight, obesity
and risk of liver cancer: a meta-analysis of cohort studies. Br J
Cancer. 97:1005–1008. 2007.PubMed/NCBI
|
|
50.
|
Moller H, Mellemgaard A, Lindvig K and
Olsen JH: Obesity and cancer risk: a Danish record-linkage study.
Eur J Cancer. 30A:344–350. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Oh SW, Yoon YS and Shin SA: Effects of
excess weight on cancer incidences depending on cancer sites and
histologic findings among men: Korea National Health Insurance
Corporation Study. J Clin Oncol. 23:4742–4754. 2005. View Article : Google Scholar
|
|
52.
|
Drakesmith H and Prentice A: Viral
infection and iron metabolism. Nat Rev Microbiol. 6:541–552. 2008.
View Article : Google Scholar
|
|
53.
|
Sorrentino P, D'Angelo S, Ferbo U, Micheli
P, Bracigliano A and Vecchione R: Liver iron excess in patients
with hepatocellular carcinoma developed on non-alcoholic
steatohepatitis. J Hepatol. 50:351–357. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54.
|
Ioannou GN, Weiss NS and Kowdley KV:
Relationship between transferrin-iron saturation, alcohol
consumption, and the incidence of cirrhosis and liver cancer. Clin
Gastroenterol Hepatol. 5:624–629. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
55.
|
Harada K, Hirohara J, Ueno Y, Nakano T,
Kakuda Y, Tsubouchi H, Ichida T and Nakanuma Y: Incidence of and
risk factors for hepatocellular carcinoma in primary biliary
cirrhosis: national data from Japan. Hepatology. 57:1942–1949.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
56.
|
Migita K, Watanabe Y, Jiuchi Y, Nakamura
Y, Saito A, Yagura M, Ohta H, Shimada M, Mita E, Hijioka T,
Yamashita H, Takezaki E, Muro T, Sakai H, Nakamuta M, Abiru S,
Komori A, Ito M, Yatsuhashi H, Nakamura M and Ishibashi H: Japanese
NHO-Liver-network study group: Hepatocellular carcinoma and
survival in patients with autoimmune hepatitis (Japanese National
Hospital Organization-autoimmune hepatitis prospective study).
Liver Int. 32:837–844. 2012. View Article : Google Scholar
|
|
57.
|
Harnois DM, Gores JG, Ludwig J, Steers JL,
LaRusso NE and Wiesner RH: Are patients with cirrhotic stage
primary sclerosing cholangitis at risk for the development of
hepatocellular cancer? J Hepatol. 27:512–516. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
58.
|
Razumilava N, Gores GJ and Lindor KD:
Cancer surveillance in patients with primary sclerosing
cholangitis. Hepatology. 54:1842–1852. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
59.
|
Edwards CQ, Griffen LM, Goldgar D,
Drummond C, Skolnick MH and Kushner JP: Prevalence of
hemochromatosis among 11,065 presumably healthy blood donors. N
Engl J Med. 318:1355–1362. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
60.
|
Powell LW, Subramaniam VN and Yapp TR:
Haemochromatosis in the new millennium. J Hepatol. 32:48–62. 2000.
View Article : Google Scholar
|
|
61.
|
Hsing AW, McLaughlin JK, Olsen JH,
Mellemkjar L, Wacholder S and Fraumeni JF Jr: Cancer risk following
primary hemochromatosis: a population-based cohort study in
Denmark. Int J Cancer. 60:160–162. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
62.
|
Fracanzani AL, Conte D, Fraquelli M,
Taioli E, Mattioli M, Losco A and Fargion S: Increased cancer risk
in a cohort of 230 patients with hereditary hemochromatosis in
comparison to matched control patients with non-iron-related
chronic liver disease. Hepatology. 33:647–651. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
63.
|
Yang Q, McDonnell SM, Khoury MJ, Cono J
and Parrish RG: Hemochromatosis-associated mortality in the United
States from 1979 to 1992: an analysis of multiple-cause mortality
data. Ann Intern Med. 129:946–953. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
64.
|
Elmberg M, Hultcrantz R, Ekbom A, Brandt
L, Olsson S, Olsson R, Lindgren S, Lööf L, Stål P, Wallerstedt S,
Almer S, Sandberg-Gertzén H and Askling J: Cancer risk in patients
with hereditary hemochromatosis and in their first-degree
relatives. Gastroenterology. 125:1733–1741. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
65.
|
Wang Y, Xie CL, Fu DL, Lu L, Lin Y, Dong
QQ, Wang XT and Zheng GQ: Clinical efficacy and safety of Chinese
herbal medicine for Wilson's disease: a systematic review of 9
randomized controlled trials. Complement Ther Med. 20:143–154.
2012.
|
|
66.
|
Michitaka K, Nishiguchi S, Aoyagi Y, Hiasa
Y, Tokumoto Y and Onji M: Japan Etiology of Liver Cirrhosis Study
Group: Etiology of liver cirrhosis in Japan: a nationwide survey. J
Gastroenterol. 45:86–94. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
67.
|
Tanaka M and Wanless IR: Pathology of the
liver in Budd-Chiari syndrome: portal vein thrombosis and the
histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and
large regenerative nodules. Hepatology. 27:488–496. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
68.
|
Okuda K: Inferior vena cava thrombosis at
its hepatic portion (obliterative hepatocavopathy). Semin Liver
Dis. 22:15–26. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
69.
|
Ren W, Qi X, Yang Z, Han G and Fan D:
Prevalence and risk factors of hepatocellular carcinoma in
Budd-Chiari syndrome: a systematic review. Eur J Gastroenterol
Hepatol. 25:830–841. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
70.
|
Raimondo G, Pollicino T, Cacciola I and
Squadrito G: Occult hepatitis B virus infection. J Hepatol.
46:160–170. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
71.
|
Raimondo G, Allain JP, Brunetto MR,
Buendia MA, Chen DS, Colombo M, Craxì A, Donato F, Ferrari C, Gaeta
GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU,
Pawlotsky JM, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D,
Smedile A, Squadrito G, Trépo C, Villa E, Will H, Zanetti AR and
Zoulim F: Statements from the Taormina expert meeting on occult
hepatitis B virus infection. J Hepatol. 49:652–657. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
72.
|
Nishikawa H, Arimoto A, Wakasa T, Kita R,
Kimura T and Osaki Y: Lack of correlation between the antibody to
hepatitis B core antigen and survival after surgical resection for
hepatitis C virus-related hepatocellular carcinoma. Oncol Rep.
30:91–98. 2013.
|
|
73.
|
Raimondo G, Caccamo G, Filomia R and
Pollicino T: Occult HBV infection. Semin Immunopathol. 35:39–52.
2013. View Article : Google Scholar
|
|
74.
|
Squadrito G, Pollicino T, Cacciola I,
Caccamo G, Villari D, La Masa T, Restuccia T, Cucinotta E, Scisca
C, Magazzu D and Raimondo G: Occult hepatitis B virus infection is
associated with the development of hepatocellular carcinoma in
chronic hepatitis C patients. Cancer. 106:1326–1330. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
75.
|
Pollicino T, Squadrito G, Cerenzia G,
Cacciola I, Raffa G, Craxi A, Farinati F, Missale G, Smedile A,
Tiribelli C, Villa E and Raimondo G: Hepatitis B virus maintains
its pro-oncogenic properties in the case of occult HBV infection.
Gastroenterology. 126:102–110. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
76.
|
Wu HC and Santella R: The role of
aflatoxins in hepatocellular carcinoma. Hepat Mon.
12:e72382012.PubMed/NCBI
|
|
77.
|
Chen CJ, Wang LY, Lu SN, Wu MH, You SL,
Zhang YJ, Wang LW and Santella RM: Elevated aflatoxin exposure and
increased risk of hepatocellular carcinoma. Hepatology. 24:38–42.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
78.
|
Kawaguchi T, Izumi N, Charlton MR and Sata
M: Branched-chain amino acids as pharmacological nutrients in
chronic liver disease. Hepatology. 54:1063–1070. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
79.
|
Price JA, Kovach SJ, Johnson T, Koniaris
LG, Cahill PA, Sitzmann JV and McKillop IH: Insulin-like growth
factor I is a comitogen for hepatocyte growth factor in a rat model
of hepatocellular carcinoma. Hepatology. 36:1089–1097. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
80.
|
Buzzelli G, Dattolo P, Pinzani M, Brocchi
A, Romano S and Gentilini P: Circulating growth hormone and
insulin-like growth factor-I in nonalcoholic liver cirrhosis with
or without superimposed hepatocarcinoma: evidence of an altered
circadian rhythm. Am J Gastroenterol. 88:1744–1748. 1993.
|
|
81.
|
Kasprzak A and Adamek A: The insulin-like
growth factor (IGF) signaling axis and hepatitis C virus-associated
carcinogenesis (Review). Int J Oncol. 41:1919–1931. 2012.PubMed/NCBI
|
|
82.
|
Shimizu M, Kubota M, Tanaka T and Moriwaki
H: Nutraceutical approach for preventing obesity-related colorectal
and liver carcinogenesis. Int J Mol Sci. 13:579–595. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
83.
|
Hirosumi J, Tuncman G, Chang L, Görgün CZ,
Uysal KT, Maeda K, Karin M and Hotamisligil GS: A central role for
JNK in obesity and insulin resistance. Nature. 420:333–336. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
84.
|
Puri P, Mirshahi F, Cheung O, Natarajan R,
Maher JW, Kellum JM and Sanyal AJ: Activation and dysregulation of
the unfolded protein response in nonalcoholic fatty liver disease.
Gastroenterology. 134:568–576. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
85.
|
Duan XF, Tang P, Li Q and Yu ZT: Obesity,
adipokines and hepatocellular carcinoma. Int J Cancer. Feb
12–2013.(Epub ahead of print).
|
|
86.
|
Asano T, Watanabe K, Kubota N, Gunji T,
Omata M, Kadowaki T and Ohnishi S: Adiponectin knockout mice on
high fat diet develop fibrosing steatohepatitis. J Gastroenterol
Hepatol. 24:1669–1676. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
87.
|
Brakenhielm E, Veitonmäki N, Cao R, Kihara
S, Matsuzawa Y, Zhivotovsky B, Funahashi T and Cao Y:
Adiponectin-induced antiangiogenesis and antitumor activity involve
caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci
USA. 101:2476–2481. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
88.
|
Kitade M, Yoshiji H, Kojima H, Ikenaka Y,
Noguchi R, Kaji K, Yoshii J, Yanase K, Namisaki T and Asada K:
Leptin-mediated neovascularization is a prerequisite for
progression of nonalcoholic steatohepatitis in rats. Hepatology.
44:983–991. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
89.
|
Ikejima K, Takei Y, Honda H, Hirose M,
Yoshikawa M, Zhang YJ, Lang T, Fukuda T, Yamashina S, Kitamura T
and Sato N: Leptin receptor-mediated signaling regulates hepatic
fibrogenesis and remodeling of extracellular matrix in the rat.
Gastroenterology. 122:1399–1410. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
90.
|
Angulo P: Nonalcoholic fatty liver
disease. N Engl J Med. 346:1221–1231. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
91.
|
Yang S, Zhu H, Li Y, Lin H, Gabrielson K,
Trush MA and Diehl AM: Mitochondrial adaptations to obesity-related
oxidant stress. Arch Biochem Biophys. 378:259–268. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
92.
|
Nowsheen S, Aziz K, Kryston TB, Ferguson
NF and Georgakilas A: The interplay between inflammation and
oxidative stress in carcinogenesis. Curr Mol Med. 12:672–680. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
93.
|
Marnett LJ: Oxyradicals and DNA damage.
Carcinogenesis. 21:361–370. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
94.
|
Petta S and Craxì A: Hepatocellular
carcinoma and non-alcoholic fatty liver disease: from a clinical to
a molecular association. Curr Pharm Des. 16:741–752. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
95.
|
Ishii H, Horie Y, Ohshima S, Anezaki Y,
Kinoshita N, Dohmen T, Kataoka E, Sato W, Goto T and Sasaki J:
Eicosapentaenoic acid ameliorates steatohepatitis and
hepatocellular carcinoma in hepatocyte-specific Pten-deficient
mice. J Hepatol. 50:562–571. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
96.
|
Ratziu V, Giral P, Charlotte F, Bruckert
E, Thibault V, Theodorou I, Khalil L, Turpin G, Opolon P and
Poynard T: Liver fibrosis in overweight patients. Gastroenterology.
118:1117–1123. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
97.
|
Adinolfi LE, Gambardella M, Andreana A,
Tripodi MF, Utili R and Ruggiero G: Steatosis accelerates the
progression of liver damage of chronic hepatitis C patients and
correlates with specific HCV genotype and visceral obesity.
Hepatology. 33:1358–1364. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
98.
|
Westin J, Nordlinder H, Lagging M,
Norkrans G and Wejstal R: Steatosis accelerates fibrosis
development over time in hepatitis C virus genotype 3 infected
patients. J Hepatol. 37:837–842. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
99.
|
Takuma Y and Nouso K: Nonalcoholic
steatohepatitis-associated hepatocellular carcinoma: our case
series and literature review. World J Gastroenterol. 16:1436–1441.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
100.
|
Duan XY, Qiao L and Fan JG: Clinical
features of nonalcoholic fatty liver disease-associated
hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 11:18–27.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
101.
|
Reddy SK, Steel JL, Chen HW, DeMateo DJ,
Cardinal J, Behari J, Humar A, Marsh JW, Geller DA and Tsung A:
Outcomes of curative treatment for hepatocellular cancer in
nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver
disease. Hepatology. 55:1809–1819. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
102.
|
Li T, Qin LX, Gong X, Zhou J, Sun HC, Qiu
SJ, Ye QH, Wang L and Fan J: Hepatitis B virus surface
antigen-negative and hepatitis C virus antibody-negative
hepatocellular carcinoma: clinical characteristics, outcome, and
risk factors for early and late intrahepatic recurrence after
resection. Cancer. 119:126–135. 2013. View Article : Google Scholar
|
|
103.
|
Malik SM, Gupte PA, de Vera ME and Ahmad
J: Liver transplantation in patients with nonalcoholic
steatohepatitis-related hepatocellular carcinoma. Clin
Gastroenterol Hepatol. 7:800–806. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
104.
|
Giannini EG, Marabotto E, Savarino V,
Trevisani F, di Nolfo MA, Del Poggio P, Benvegnù L, Farinati F,
Zoli M and Borzio F: Hepatocellular carcinoma in patients with
cryptogenic cirrhosis. Clin Gastroenterol Hepatol. 7:580–585. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
105.
|
Tokushige K, Hashimoto E, Yatsuji S,
Tobari M, Taniai M, Torii N and Shiratori K: Prospective study of
hepatocellular carcinoma in nonalcoholic steatohepatitis in
comparison with hepatocellular carcinoma caused by chronic
hepatitis C. J Gastroenterol. 45:960–967. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
106.
|
Kusakabe A, Tanaka Y, Orito E, Sugauchi F,
Kurbanov F, Sakamoto T, Shinkai N, Hirashima N, Hasegawa I, Ohno T,
Ueda R and Mizokami M: A weak association between occult HBV
infection and non-B non-C hepatocellular carcinoma in Japan. J
Gastroenterol. 42:298–305. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
107.
|
Hatanaka K, Kudo M, Fukunaga T, Ueshima K,
Chung H, Minami Y, Sakaguchi Y, Hagiwara S, Orino A and Osaki Y:
Clinical characteristics of nonBnonC-HCC: comparison with HBV and
HCV related HCC. Intervirology. 50:24–31. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
108.
|
Nishikawa H, Osaki Y, Takeda H, Sakamoto
A, Saito S, Nishijima N, Nasu A, Arimoto A, Kita R and Kimura T:
Effect of body mass index on survival after curative therapy for
non-B non-C hepatocellular carcinoma. J Gastrointestin Liver Dis.
22:173–181. 2013.PubMed/NCBI
|
|
109.
|
Cauchy F, Zalinski S, Dokmak S, Fuks D,
Farges O, Castera L, Paradis V and Belghiti J: Surgical treatment
of hepatocellular carcinoma associated with the metabolic syndrome.
Br J Surg. 100:113–121. 2013. View Article : Google Scholar : PubMed/NCBI
|
